Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
RCT |
60 pre-menopausal women with cyclical breast pain |
Hot flushes
8/31 (26%) with tamoxifen 20 mg daily 3/29 (10%) with placebo |
Reported as not significant |
Not significant | |
RCT |
60 pre-menopausal women with cyclical breast pain |
Vaginal discharge
5/31 (16%) with tamoxifen 20 mg daily 2/29 (7%) with placebo |
Reported as not significant |
Not significant | |
RCT 3-armed trial |
93 women |
Hot flushes
8/32 (25%) with tamoxifen 10 mg daily 3/29 (10%) with placebo |
P value not reported |
||
RCT 3-armed trial |
93 women |
Vaginal discharge
5/32 (16%) with tamoxifen 10 mg daily 2/29 (7%) with placebo |
P value not reported |
||
RCT |
88 women aged 22 to 44 years |
Adverse effects
with tamoxifen with placebo |